Latest Distributions News

Osteopore Limited has secured an exclusive agreement with MontsMed Hong Kong to introduce its innovative 3D-printed orthopaedic implants into Hong Kong, positioning itself strategically within the Greater Bay Area’s burgeoning medical market.

BWP Group has updated its dividend announcement, confirming an estimated unfranked dividend of 9.58 cents per security for the half-year ending December 2025, alongside details of its dividend reinvestment plan pricing.

GenusPlus Group has raised its FY2026 EBITDA guidance by approximately 35%, driven by robust half-year results and recent contract wins across its Energy & Engineering and Services segments.

N1 Holdings Limited has reported a strong December quarter with rising revenue, net profit, and cash receipts, underpinned by SME lending growth and funding efficiency improvements. The company also navigates increased regulatory scrutiny with a firm commitment to conservative lending.

Alternative Investment Trust (ASX, AIQ) has announced a special unfranked distribution of 3.559 cents per unit, representing a full return of capital payable in February 2026.

Gibb River Diamonds reports completion of ore processing at Three Mile Hill and ongoing operations at Lakewood, recovering significant gold ounces and generating early revenue. Mining challenges at Neta Pit have impacted grades but are partly offset by increased tonnage and gold prices.

AMCIL Limited has announced a fully franked ordinary dividend of AUD 0.01 per share for the half-year ending December 2025, with options for dividend reinvestment and bonus securities.

Enova Mining has completed over 65% of its diamond drilling program at the East Salinas rare earth project in Brazil, with initial assay results expected by early February. The drilling targets high-grade rare earth mineralisation across multiple prospects, aiming to confirm continuity and support resource development.

Osteopore Limited has inked a three-year exclusive distribution agreement with MontsMed to introduce its advanced orthopaedic trauma reconstruction products into Hong Kong, positioning itself strategically within the Greater Bay Area.

LTR Pharma has initiated dosing in its Phase II clinical trial for SPONTAN, a rapid-acting intranasal spray targeting erectile dysfunction, marking a key step toward FDA approval and commercial expansion.

Regis Resources has reported a robust December quarter marked by record cash generation and an extended mine life at Duketon North, underpinned by disciplined costs and promising exploration results.

Spheria Emerging Companies Limited announces a fully franked 3.8 cents per share quarterly dividend for December 2025 and initiates monthly dividends of 1.3 cents for February and March 2026 as it transitions dividend payments from quarterly to monthly.